Global Alpha-1 Antitrypsin Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 144262
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Alpha-1 antitrypsin deficiency is a genetic disease, which means it's passed down from your parents. It can cause serious lung disease that makes it hard to breathe. It can also cause liver disease that leads to jaundice, which makes skin look yellowish.

Scope of the Report:

This report focuses on the Alpha-1 Antitrypsin Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Alpha-1 Antitrypsin Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Baxter

CSL Behring

Grifols

Kamada

Abeona Therapeutics

Alnylam Pharmaceuticals

Applied Genetic Technologies

Arrowhead Research Corporation

Baxalta

Biogen

Chiesi Pharmaceuticals

Curaxys

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Parenteral

Inhalation

Market Segment by Applications, can be divided into

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

There are 15 Chapters to deeply display the global Alpha-1 Antitrypsin Drugs market.

Chapter 1, to describe Alpha-1 Antitrypsin Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Alpha-1 Antitrypsin Drugs, with sales, revenue, and price of Alpha-1 Antitrypsin Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Alpha-1 Antitrypsin Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Alpha-1 Antitrypsin Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Alpha-1 Antitrypsin Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Alpha-1 Antitrypsin Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Parenteral

1.2.2 Inhalation

1.3 Market Analysis by Applications

1.3.1 Hospital Pharmacy

1.3.2 Retail Pharmacy

1.3.3 Online Pharmacy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Baxter

2.1.1 Business Overview

2.1.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 CSL Behring

2.2.1 Business Overview

2.2.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Grifols

2.3.1 Business Overview

2.3.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Kamada

2.4.1 Business Overview

2.4.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Abeona Therapeutics

2.5.1 Business Overview

2.5.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Alnylam Pharmaceuticals

2.6.1 Business Overview

2.6.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Applied Genetic Technologies

2.7.1 Business Overview

2.7.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Applied Genetic Technologies Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Arrowhead Research Corporation

2.8.1 Business Overview

2.8.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Baxalta

2.9.1 Business Overview

2.9.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Biogen

2.10.1 Business Overview

2.10.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Biogen Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Chiesi Pharmaceuticals

2.11.1 Business Overview

2.11.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Chiesi Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Curaxys

2.12.1 Business Overview

2.12.2 Alpha-1 Antitrypsin Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Curaxys Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Alpha-1 Antitrypsin Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Alpha-1 Antitrypsin Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Alpha-1 Antitrypsin Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Alpha-1 Antitrypsin Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Alpha-1 Antitrypsin Drugs Market Analysis by Regions

4.1 Global Alpha-1 Antitrypsin Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Alpha-1 Antitrypsin Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

4.5 South America Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

5 North America Alpha-1 Antitrypsin Drugs by Countries

5.1 North America Alpha-1 Antitrypsin Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Alpha-1 Antitrypsin Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Alpha-1 Antitrypsin Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

6 Europe Alpha-1 Antitrypsin Drugs by Countries

6.1 Europe Alpha-1 Antitrypsin Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Alpha-1 Antitrypsin Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

6.3 UK Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

6.4 France Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Alpha-1 Antitrypsin Drugs by Countries

7.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

7.5 India Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

8 South America Alpha-1 Antitrypsin Drugs by Countries

8.1 South America Alpha-1 Antitrypsin Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Alpha-1 Antitrypsin Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Alpha-1 Antitrypsin Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Alpha-1 Antitrypsin Drugs by Countries

9.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2013-2018)

10 Global Alpha-1 Antitrypsin Drugs Market Segment by Type

10.1 Global Alpha-1 Antitrypsin Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Alpha-1 Antitrypsin Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Type (2013-2018)

10.2 Parenteral Sales Growth and Price

10.2.1 Global Parenteral Sales Growth (2013-2018)

10.2.2 Global Parenteral Price (2013-2018)

10.3 Inhalation Sales Growth and Price

10.3.1 Global Inhalation Sales Growth (2013-2018)

10.3.2 Global Inhalation Price (2013-2018)

11 Global Alpha-1 Antitrypsin Drugs Market Segment by Application

11.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Pharmacy Sales Growth (2013-2018)

11.3 Retail Pharmacy Sales Growth (2013-2018)

11.4 Online Pharmacy Sales Growth (2013-2018)

12 Alpha-1 Antitrypsin Drugs Market Forecast (2018-2023)

12.1 Global Alpha-1 Antitrypsin Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Alpha-1 Antitrypsin Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Alpha-1 Antitrypsin Drugs Market Forecast (2018-2023)

12.2.2 Europe Alpha-1 Antitrypsin Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Forecast (2018-2023)

12.2.4 South America Alpha-1 Antitrypsin Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Forecast (2018-2023)

12.3 Alpha-1 Antitrypsin Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Alpha-1 Antitrypsin Drugs Market Share Forecast by Type (2018-2023)

12.4 Alpha-1 Antitrypsin Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Alpha-1 Antitrypsin Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Alpha-1 Antitrypsin Drugs Picture

Table Product Specifications of Alpha-1 Antitrypsin Drugs

Figure Global Sales Market Share of Alpha-1 Antitrypsin Drugs by Types in

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery